Literature DB >> 6406805

Characterization of human interferon-gamma-producing leukocytes with monoclonal antileukocyte antibodies.

J Abb, H Abb, F Deinhardt.   

Abstract

Monoclonal antibodies with specificities for subsets of human leukocytes have been used for the characterization of interferon (IFN) gamma-producing cells. The production of IFN gamma was demonstrated to be a function of OKT3+T lymphocytes. The capacity to secrete IFN gamma was not restricted to the OKT4+ or the OKT8+T-cell subset. BA-1+B lymphocytes and Leu7+ natural killer cells did not contribute to the production of IFN gamma. Ia+, OKM1+ monocytes served an auxiliary function in the production of IFN gamma. The requirement for accessory monocytes, however, was not absolute, because monocyte-free preparations of long-term cultured IL2-dependent T lymphocytes retained the capacity to secrete IFN gamma.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6406805     DOI: 10.1007/BF02123495

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  27 in total

1.  A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

2.  C-type virus associated with gibbon lymphosarcoma.

Authors:  T G Kawakami; S D Huff; P M Buckley; D L Dungworth; S P Synder; R V Gilden
Journal:  Nat New Biol       Date:  1972-02-09

3.  Production of immune interferon by murine T-cell clones from long-term cultures.

Authors:  F Marcucci; M Waller; H Kirchner; P Krammer
Journal:  Nature       Date:  1981-05-07       Impact factor: 49.962

4.  Separation of functional subsets of human T cells by a monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

5.  Identification of the T cell subset that produces human gamma interferon.

Authors:  J A O'Malley; A Nussbaum-Blumenson; D Sheedy; B J Grossmayer; H Ozer
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

6.  A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

7.  Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon.

Authors:  J E Blalock; J A Georgiades; M P Langford; H M Johnson
Journal:  Cell Immunol       Date:  1980-02       Impact factor: 4.868

8.  Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression.

Authors:  E L Reinherz; P C Kung; J M Pesando; J Ritz; G Goldstein; S F Schlossman
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

9.  Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells.

Authors:  H Rabin; R F Hopkins; F W Ruscetti; R H Neubauer; R L Brown; T G Kawakami
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

10.  Retinoic acid suppression of human leukocyte interferon production.

Authors:  J Abb; H Abb; F Deinhardt
Journal:  Immunopharmacology       Date:  1982-08
View more
  4 in total

1.  HIV-associated myocarditis. Pathology and immunopathology.

Authors:  W E Beschorner; K Baughman; R P Turnicky; G M Hutchins; S A Rowe; A L Kavanaugh-McHugh; D L Suresch; A Herskowitz
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

2.  Age-related decline of human interferon alpha and interferon gamma production.

Authors:  J Abb; H Abb; F Deinhardt
Journal:  Blut       Date:  1984-05

3.  Serum interferon and clinical manifestations of infection with human T-lymphotropic virus type III.

Authors:  J Abb
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

Review 4.  Emerging agents and regimens for AML.

Authors:  Hongtao Liu
Journal:  J Hematol Oncol       Date:  2021-03-23       Impact factor: 17.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.